Domp_ is a leading Italian biopharmaceutical company and its main focus is developing innovative treatment solutions for rare, often orphan, diseases. The Group pursues its corporate mission by promoting and actively participating in a network made up of the best names in each activity of the pharmaceutical industry, from research to development, from production to marketing. Domp_ has its headquarters in Milan, its major industrial and biotechnology research site in LÍAquila employing 250 people _ of whom 70 in R&D _, and another Research & Development unit in Naples. As part of its international development strategy, Domp_ opened in 2014 its offices in New York to coordinate the R&D activities in North America. In 2015, offices were opened in Tirana, where the Group markets its Primary Care product portfolio, and in Barcelona, in order to follow the ongoing collaborations with research centres in Spain aimed at developing innovative biotechnology solutions. In 2016, offices are planned to be opened in United Kingdom, Germany and France. In 2016, the Group will invest 30% of its revenues in Research & Development, focusing on areas with unmet treatment needs such as ophthalmology, oncology, diabetes and organ transplantation. For more information on Domp_ visit www.dompe.com To explore career opportunities at Domp_ visit www.dompe.com/Selection-and-Recruiting/